JVMTX | MRRFX | JVMTX / MRRFX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 11 years | 22 years | - |
Gain YTD | 10.022 | 6.616 | 151% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.4B | 1.07B | 2,185% |
Annual Yield % from dividends | 0.73 | 1.61 | 45% |
Returns for 1 year | 16.17 | 11.48 | 141% |
Returns for 3 years | 10.42 | 3.29 | 316% |
Returns for 5 years | 42.36 | 27.80 | 152% |
Returns for 10 years | 58.91 | -10.57 | -557% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QSPT | 26.55 | 0.01 | +0.04% |
FT Cboe Vest Nasdaq-100® Buffer ETF Sep | |||
FTA | 78.40 | -0.08 | -0.11% |
First Trust Large Cap Val AlphaDEX® ETF | |||
LFEQ | 47.52 | -0.06 | -0.14% |
VanEck Lg/Flat Trend ETF | |||
IEFA | 75.96 | -0.21 | -0.28% |
iShares Core MSCI EAFE ETF | |||
BIB | 66.68 | -0.58 | -0.86% |
ProShares Ultra Nasdaq Biotechnology |